JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 34 No. 4 649-657
© 1993 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sloof, G. W.
Right arrow Articles by Knapp, F. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sloof, G. W.
Right arrow Articles by Knapp, F. F., Jr.

Comparison of Uptake, Oxidation and Lipid Distribution of 17-Iodoheptadecanoic Acid, 15-(p-Iodophenyl)Pentadecanoic Acid and 15-(p-Iodophenyl)-3,3-Dimethylpentadecanoic Acid in Normal Canine Myocardium

Gerrit W. Sloof, Frans C. Visser, Machiel J. Eenige van, Emile F.I. Comans, Tom Teerlink, Jacobus D.M. Herscheid, Ger J. Van der Vusse and Furn F. (Russ) Knapp, Jr.

Dept. of Cardiology, Metabolic Laboratory, Radionuclide Centre, Free University Hospital, Amsterdam, The Netherlands
Dept. of Physiology, University of Limburg, Maastricht, The Netherlands
Nuclear Medicine Group, Oak Ridge National Laboratory, Oak Ridge, Tennessee

Correspondence: For correspondence and reprints contact: Gerrit W. Sloof, MD, Dept. of Cardiology, Free University Hospital, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

ABSTRACT

The kinetics of 17-[123]iodoheptadecanoic acid (IHDA), 15-(p-[125I]iodophenyl)pentadecanoic acid (pIPPA) and 15-(p-131I]iodophenyl)-3,3-dimethylpentadecanoic acid (DMIPPA) were investigated in normal canine myocardium. After simultaneous Intravenous injection, myocardial biopsy specimens and samples of arterial blood were taken over 80 min. IHDA showed the highest myocardial uptake (995 ± 248 dpm/mg-mCi versus pIPPA: 785 ± 197 dpm/mg-mCi, ns) and the largest size of oxidation (74% ± 4% versus pIPPA: 65% ± 5%, p < 0.05). Myocardial activity of IHDA decreased with a half-time value of 11.2 min (pIPPA: 13.2 min). Phospholipids were the main lipid fraction into which IHDA was incorporated, whereas pIPPA was predominantly incorporated into triacylglycerols. DMIPPA myocardial activity remained constant during the assay period and instead of being oxidized, DMIPPA was mainly incorporated into triacylglycerols (55% ± 12%). The myocardium-to-blood ratios of DMIPPA were greater than 10:1. The ratios at peak for IHDA and pIPPA were 4.1:1 and 3.9:1, respectively(both p < 0.0001 versus DMIPPA). In conclusion, differences have been found in the myocardial uptake, oxidation and lipid distribution of IHDA, pIPPA and DMIPPA. DMIPPA is a promising tracer for fatty acid uptake studies with single-photon emission computerized tomography because of its prolonged retention and high myocardium-to-blood ratios.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1993 by the Society of Nuclear Medicine.